Ferring Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for FERRING PHARMS INC, and what generic alternatives to FERRING PHARMS INC drugs are available?
FERRING PHARMS INC has nine approved drugs.
There are eighteen US patents protecting FERRING PHARMS INC drugs.
There are one hundred and eighty-three patent family members on FERRING PHARMS INC drugs in thirty-nine countries and thirteen supplementary protection certificates in eight countries.
Summary for Ferring Pharms Inc
International Patents: | 183 |
US Patents: | 18 |
Tradenames: | 9 |
Ingredients: | 4 |
NDAs: | 9 |
Drugs and US Patents for Ferring Pharms Inc
Expired US Patents for Ferring Pharms Inc
Paragraph IV (Patent) Challenges for FERRING PHARMS INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Oral Solution | 10 mg, 3.5 g, and12 g | ➤ Subscribe | 2019-02-11 |
➤ Subscribe | Oral Solution | 10 mg, 3.5 g, and 12 g | ➤ Subscribe | 2014-05-21 |
International Patents for Ferring Pharms Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Denmark | 2296686 | See Plans and Pricing |
Spain | 2645630 | See Plans and Pricing |
Spain | 2559446 | See Plans and Pricing |
Lithuania | 2249757 | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2012001469 | See Plans and Pricing |
Croatia | P20190114 | See Plans and Pricing |
Spain | 2677548 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ferring Pharms Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3225249 | 2019C/520 | Belgium | See Plans and Pricing | PRODUCT NAME: DESMOPRESSINE OF EEN ACETAATZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: BE497271 - BE497280 20160513 |
3225249 | CA 2019 00023 | Denmark | See Plans and Pricing | PRODUCT NAME: DESMOPRESSIN ELLER ET ACETATSALT DERAF; NAT. REG. NO/DATE: 55858, 55859 (DK) 20160526; FIRST REG. NO/DATE: BE BE497271, BE497280 20160504 |
2782584 | 301153 | Netherlands | See Plans and Pricing | PRODUCT NAME: COMPOSITION CONTAINING BOTH ESTRADIOL (17SS-ESTRADIOL), OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE OR SOLVATE THEREOF (INCLUDING IN HEMIHYDRATE FORM), AND PROGESTERONE; NATIONAL REGISTRATION NO/DATE: RVG 125821 20210611; FIRST REGISTRATION: BE BE582231 20210406 |
2782584 | LUC00245 | Luxembourg | See Plans and Pricing | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL (17SS-ESTRADIOL), EVENTUELLEMENT SOUS FORME D'UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI (Y COMPRIS SOUS FORME HEMIHYDRATEE), ET DE LA PROGESTERONE; AUTHORISATION NUMBER AND DATE: BE582231 20210701 |
2712622 | LUC00015 | Luxembourg | See Plans and Pricing | PRODUCT NAME: DESMOPRESSINE OU UN DE SES SELS D'ACETATE; AUTHORISATION NUMBER AND DATE: 497271; 497280 20161101 |
2712622 | PA2017001 | Lithuania | See Plans and Pricing | PRODUCT NAME: DESMOPRESINAS ARBA JO ACETATO DRUSKA; REGISTRATION NO/DATE: BE497271, 2016-05-04; LT1-16/3940/001-LT/1 6/3940/008 |
3225249 | 300983 | Netherlands | See Plans and Pricing | PRODUCT NAME: DESMOPRESSIN, DESGEWENST IN DE VORM VAN EEN ACETAAT ZOUT; REGISTRATION NO/DATE: BE497271 & BE497280 20160513 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.